Similarly, crizotinib also showed therapeutic responses in ALK-fusion-positive inflammatory myofibroblastic tumor (IMT) patients [88] and paediatric patients with ALCL and IMT [89]. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.